Research & Development



  雲瑯笑道︰“這屋子里的門戶太多,君侯的傷口如今正在痊愈中,還是不要見風的好,換一間吧。”   阿嬌嘿嘿笑道︰“知道不,你是第一個如此強硬跟陛下對抗的人。”香蕉伊人影院手机在线观看   “這一點我是知道的,阿襄跟我說過,大漢武侯永遠都不能擰成一股繩,更不能齊心協力,否則就是大禍臨頭之日。所以,我了解,即便是公孫進暗算了你,大將軍並沒有為你討回公道。我甚至知道,當年公孫進之所以會暗算你,純粹是公孫進自己的想法,與公孫敖無關。”香蕉伊人影院国产在线观看   甦建點點頭,覺得公孫敖說的很對,公孫賀也覺得公孫敖今天難得的聰慧了一次,很是欣慰。   志得意滿的董仲舒為這一場戰爭敲響了結束的鐘鼓。热热热色色原网站   隋越听皇帝提到了阿嬌,額頭上的汗水一下子就出來了,小聲道︰“陛下,可不敢讓阿嬌貴人知曉是奴婢出的主意啊。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo